Breaking news from “The Pink Sheet” DAILY
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including the approval of Bristol-Myers Squibb/Otsuka's antipsychotic Abilify for use in acute bipolar mania, J&J's subpoena from the HHS Inspector General requesting documents relating to its sales and marketing of Procrit and Gov. Schwarzenegger's vetoes of California importation legislation. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...
You may also be interested in...
New directors at 4D Pharma, Neurogene And Zogenix.
Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.
In an exclusive interview with Generics Bulletin, Inflexion’s Ben Long reveals his ambitions for newly-acquired UK-based liquids generics specialist Rosemont Pharmaceuticals, including to drive investment in R&D and expand the company’s international footprint.